Autosomal dominant polycystic kidney disease: Genetics, mutations and microRNAs

被引:58
作者
Tan, Ying-Cai [1 ]
Blumenfeld, Jon [2 ,3 ]
Rennert, Hanna [1 ]
机构
[1] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[3] Rogosin Inst, New York, NY USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2011年 / 1812卷 / 10期
基金
美国国家卫生研究院;
关键词
ADPKD; PKD gene; Mutation; Gene variation; Polycystic kidney disease; Variants of uncertain significance; POLYCYSTIC-KIDNEY-DISEASE-1; PKD1; GENE; SEQUENCE-ANALYSIS; MODIFIER GENES; RENAL-DISEASE; PROTEIN; EXPRESSION; ADPKD; CYSTOGENESIS; PATHOGENESIS; PHENOTYPE;
D O I
10.1016/j.bbadis.2011.03.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is a common, monogenic multi-systemic disorder characterized by the development of renal cysts and various extrarenal manifestations. Worldwide, it is a common cause of end-stage renal disease. ADPKD is caused by mutation in either one of two principal genes, PKD1 and PKD2, but has large phenotypic variability among affected individuals, attributable to PKD genic and allelic variability and, possibly, modifier gene effects. Recent studies have generated considerable information regarding the genetic basis and molecular diagnosis of this disease, its pathogenesis, and potential strategies for targeted treatment. The purpose of this article is to provide a comprehensive review of the genetics of ADPKD, including mechanisms responsible for disease development, the role of gene variations and mutations in disease presentation, and the putative role of microRNAs in ADPKD etiology. The emerging and important role of genetic testing and the advent of novel molecular diagnostic applications also are reviewed. This article is part of a Special Issue entitled: Polycystic Kidney Disease. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1202 / 1212
页数:11
相关论文
共 116 条
[1]  
Aguiari G, 2000, Hum Mutat, V16, P444, DOI 10.1002/1098-1004(200011)16:5<444::AID-HUMU11>3.0.CO
[2]  
2-C
[3]  
Ariyurek Yavuz, 2004, Hum Mutat, V23, P99, DOI 10.1002/humu.9208
[4]   Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease [J].
Arnaout, MA .
ANNUAL REVIEW OF MEDICINE, 2001, 52 :93-123
[5]   DNA structural transitions within the PKD1 gene [J].
Blaszak, RT ;
Potaman, V ;
Sinden, RR ;
Bissler, JJ .
NUCLEIC ACIDS RESEARCH, 1999, 27 (13) :2610-2617
[6]   Pretransplant Genetic Testing of Live Kidney Donors at Risk for Autosomal Dominant Polycystic Kidney Disease [J].
Blumenfeld, Jon D. .
TRANSPLANTATION, 2009, 87 (01) :6-7
[7]   Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis [J].
Brasier, JL ;
Henske, EP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :194-199
[8]   Autosomal dominant polycystic kidney disease: Emerging concepts of pathogenesis and new treatments [J].
Braun, William E. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2009, 76 (02) :97-104
[9]   Mutation screening of the PKD1 transcript by RT-PCR [J].
Burtey, S ;
Lossi, AM ;
Bayle, J ;
Berland, Y ;
Fontés, M .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (06) :422-429
[10]   Overexpression of PKD2 in the mouse is associated with renal tubulopathy [J].
Burtey, Stephane ;
Riera, Marta ;
Ribe, Emilie ;
Pennekamp, Petra ;
Passage, Edith ;
Rance, Roselyne ;
Dworniczak, Bernd ;
Fontes, Michel .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) :1157-1165